Kathleen Reape
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kathleen Reape
Earlier roles on record: Board Member at Taysha Gene Therapies, Inc. (TSHA) until November 1, 2023. Taysha Gene Therapies, Inc. reported in an 8-K filed November 1, 2023 that Kathleen Reape resigned as director, effective November 1, 2023. Taysha Gene Therapies, Inc. reported in an 8-K filed April 27, 2023 that Kathleen Reape resigned as Class III director, effective November 1, 2023.
“As previously reported, on April 24, 2023, Kathleen Reape provided notice to the board of directors (the "Board") of Taysha Gene Therapies, Inc. (the "Company") of her decision to resign from the Board and all committees thereof, effective November 1, 2023, in accordance with the governance guidelines of Dr. Reape's employer and not as a result of any disagreement with the Company.”
“On April 24, 2023, Kathleen Reape provided notice to the board of directors (the "Board") of the Company of her decision to resign from the Board, effective November 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-11-23–2023-11-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.